Abstract
The present CoMFA study on thiazolidine-2,4-diones attempts to quantitatively describe the structural features of the compounds for high PPAR-γ agonistic action. A set of 50 compounds was used for the analysis. A training set and a test set were designed consisting of 39 and 11 compounds, respectively. All the molecules were modeled and energy minimized using SYBYL 6.7 software. The molecules were aligned using the most active analog as the template by field fit method. PLS (partial least square) analysis was performed on the training set and statistical parameters like q2, r2, F value and P value were calculated. A final model was generated by excluding four outliers from the training set. Cross Validation was done by leave one out method. The developed CoMFA model showed a good external as well as internal predictivity in most of the compounds with low residual values. The q2 value of the developed model was 0.549 and r2 value was 0.976. Contour plots generated from the steric and electrostatic contributions of this model were used to derive structure-activity relationships and to design a hypothetical molecular structure, which can be used as a lead for design and syntheses of newer molecules.
Keywords: CoMFA, 3D-QSAR, PPAR-γ agonists, Thiazolidine-2,4-diones, Antihyperglycemics
Letters in Drug Design & Discovery
Title: CoMFA Study on Thiazolidine-2,4-diones for their Antihyperglycemic Activity
Volume: 5 Issue: 2
Author(s): M. J. Nanjan, T. K. Praveen, B. Suresh, J. Vergheese, Bijoy J. Desai and B. R. Prashantha Kumar
Affiliation:
Keywords: CoMFA, 3D-QSAR, PPAR-γ agonists, Thiazolidine-2,4-diones, Antihyperglycemics
Abstract: The present CoMFA study on thiazolidine-2,4-diones attempts to quantitatively describe the structural features of the compounds for high PPAR-γ agonistic action. A set of 50 compounds was used for the analysis. A training set and a test set were designed consisting of 39 and 11 compounds, respectively. All the molecules were modeled and energy minimized using SYBYL 6.7 software. The molecules were aligned using the most active analog as the template by field fit method. PLS (partial least square) analysis was performed on the training set and statistical parameters like q2, r2, F value and P value were calculated. A final model was generated by excluding four outliers from the training set. Cross Validation was done by leave one out method. The developed CoMFA model showed a good external as well as internal predictivity in most of the compounds with low residual values. The q2 value of the developed model was 0.549 and r2 value was 0.976. Contour plots generated from the steric and electrostatic contributions of this model were used to derive structure-activity relationships and to design a hypothetical molecular structure, which can be used as a lead for design and syntheses of newer molecules.
Export Options
About this article
Cite this article as:
Nanjan J. M., Praveen K. T., Suresh B., Vergheese J., Desai J. Bijoy and Prashantha Kumar R. B., CoMFA Study on Thiazolidine-2,4-diones for their Antihyperglycemic Activity, Letters in Drug Design & Discovery 2008; 5 (2) . https://dx.doi.org/10.2174/157018008783928409
DOI https://dx.doi.org/10.2174/157018008783928409 |
Print ISSN 1570-1808 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-628X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Endothelial Function Assessment in Complicated Hypertension
Current Pharmaceutical Design Differential Influences of Gastric Bypass and Sleeve Gastrectomy on Plasma Nesfatin-1 and Obestatin Levels in Patients with Type 2 Diabetes Mellitus
Current Pharmaceutical Design MicroRNAs and the Heart: Small Things Do Matter
Current Topics in Medicinal Chemistry Novel Optical Techniques for Imaging Microcirculation in the Diabetic Foot
Current Pharmaceutical Design Endothelial Function in Renal Transplant Recipients is Associated with Circulating Nitric Oxide, ACE Inhibitor Use and Time After Transplantation
Vascular Disease Prevention (Discontinued) Secondary Hypertension: The Ways of Management
Current Vascular Pharmacology Glucose Sensors Based on Core@Shell Magnetic Nanomaterials and Their Application in Diabetes Management: A Review
Current Pharmaceutical Design A New Insight of Herbal Promises Against Ocular Disorders: An Occuloinformatics Approach
Current Topics in Medicinal Chemistry Regulation of Angiogenesis and Angiogenic Factors by Cardiovascular Medications
Current Pharmaceutical Design An Update on Management of Acute and Chronic Open Wounds: The Importance of Moist Environment in Optimal Wound Healing
Medicinal Chemistry Reviews - Online (Discontinued) Antidiabetic Effect of Aqueous Corrigiola telephiifolia in Streptozotocin- Induced Diabetic Rats
The Natural Products Journal Pharmacological Interactions of Paraoxonase 1 (PON1): A HDL-Bound Antiatherogenic Enzyme
Current Clinical Pharmacology Synthesis and Evaluation of Thiazolidinedione-Coumarin Adducts as Antidiabetic, Anti-Inflammatory and Antioxidant Agents
Letters in Organic Chemistry The Contrast Sensitivity Test in Early Detection of Ocular Changes in the Relation to the Type I Diabetes Mellitus Compensation in Children,Teenagers, and Young Adults
Recent Patents on Inflammation & Allergy Drug Discovery Different Pharmacokinetic Responses to an Acute Dose of Inorganic Nitrate in Patients with Type 2 Diabetes
Endocrine, Metabolic & Immune Disorders - Drug Targets Renal Tubular Acidosis
Current Pediatric Reviews Novel Approach to Cardiovascular Diseases: A Promising Probability of (Pro)Renin Receptor [(P)RR]
Current Pharmaceutical Design Beta-Blockers use for Hypertension in the Elderly
Cardiovascular & Hematological Agents in Medicinal Chemistry Drug Development from Natural Resource: A Systematic Approach
Mini-Reviews in Medicinal Chemistry Should Adipokines be Considered in the Choice of the Treatment of Obesity-Related Health Problems?
Current Drug Targets